Citation Impact
Citing Papers
Normal gut microbiota modulates brain development and behavior
2011 Standout
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
2016
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
2017
An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections
2018
Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes
2007
Vaccines against dengue: a review of current candidate vaccines at advanced development stages
2007
Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat
2000
The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.
2004 Standout
Genetic Regulation of Caenorhabditis elegans Lysosome Related Organelle Function
2013 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies
2002 Standout
Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus
2017
Structural Basis of Zika Virus-Specific Antibody Protection
2016
Descending control of pain
2002 Standout
The pathogenesis of dengue
2011
Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat
1994
Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs
2014
A Proposed Test Battery and Constellations of Specific Behavioral Paradigms to Investigate the Behavioral Phenotypes of Transgenic and Knockout Mice
1997
New developments in flavivirus vaccines with special attention to yellow fever
2005
Biological actions of cholecystokinin
1994
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Operational strategies to achieve and maintain malaria elimination
2010
Prevention of Malaria in Long-term Travelers
2006
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
1995 StandoutNatureNobel
Guillain–Barré Syndrome
2012 Standout
A review of the role of anti‐opioid peptides in morphine tolerance and dependence
1992
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
2006 Standout
Pharmacological Characterization of Morphine‐Induced In Vivo Release of Cholecystokinin in Rat Dorsal Horn
1999
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients
2009
Changes in anxiety-related behaviors and hypothalamic–pituitary–adrenal activity in mice lacking the 5-HT-3A receptor
2004 StandoutNobel
Morphine‐induced in vivo release of spinal cholecystokinin is mediated by δ‐opioid receptors – effect of peripheral axotomy
2001
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Co‐localization of endomorphin‐2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat
2004 StandoutNobel
Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats
1994
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator
2011 StandoutNobel
Molecular signaling involved in regulating feeding and other mitivated behaviors
2007
Dengue: a continuing global threat
2010 Standout
Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria
2010
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain
1993
Malaria
2013 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
2010
Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
2010
Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes
2003 StandoutNatureNobel
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine analgesic tolerance
1999
Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord
1993
Opioid and anti‐opioid peptides
1995
A locus and mechanism of action for associative morphine tolerance
2000
Towards a serotonin-dependent leptin roadmap in the brain
2011
Increased release of immunoreactive CCK-8 by electroacupuncture and enhancement of electroacupuncture analgesia by CCK-B antagonist in rat spinal cord
1993
The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food
2004
Cholecystokinin in Mammalian Primary Sensory Neurons and Spinal Cord: In Situ Hybridization Studies in Rat and Monkey
1993
Neural Science: A Century of Progress and the Mysteries that Remain
2000 StandoutNobel
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
Dengue
2012 Standout
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
2006
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target
2013 Standout
Vaccines and Guillain-Barré Syndrome
2009
THE NEUROBIOLOGY OF PLACEBO ANALGESIA: FROM ENDOGENOUS OPIOIDS TO CHOLECYSTOKININ
1997
Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy
1997
Learning and Memory Deficits in Notch Mutant Mice
2003 StandoutNobel
Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance
2003
Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material
1994
The Effects of Intrathecally Administered FK480, a Cholecystokinin-A Receptor Antagonist, and YM022, a Cholecystokinin-B Receptor Antagonist, on the Formalin Test in the Rat
1996
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
The ABC of clinical and experimental adjuvants—A brief overview
2009
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Brain serotonin system in the coordination of food intake and body weight
2010
In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCKB receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics
1997
Dengue Vaccine Candidates in Development
2009
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
2010 StandoutNobel
Neuropeptides in perspective: The last ten years
1991
Differential modulation of α2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study
1994
Prospects for a dengue virus vaccine
2007
Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
2004 StandoutNobel
Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate- CCK analgesic interactions
1992
Antinociceptive Effects of RB101, a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by a Cholecystokinin Type B Receptor Antagonist, as Revealed by Noxiously Evoked Spinal c-Fos Expression in Rats
1997
Control of Cell Adhesion and Growth with Micropatterned Supported Lipid Membranes
2001 StandoutNobel
Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons
2005
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
2008
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
2010
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Neural Science
2000 StandoutNobel
Yellow fever vaccine
2005
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
2009
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Carbon Monoxide: a Putative Neural Messenger
1993 StandoutScience
Molecular signaling involved in regulating feeding and other mitivated behaviors
2007
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Circuitry Underlying Antiopioid Actions of Cholecystokinin Within the Rostral Ventromedial Medulla
2001
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Vaccines: the Fourth Century
2009
Works of Scott Kitchener being referenced
Population pharmacokinetics of mefloquine for malaria prophylaxis in Australian soldiers
2006
Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All
2006
The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific
2008
An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats
1994
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults☆
2005
When Should Travelers from Nonendemic Areas for Flaviviruses Receive Booster Vaccination for Japanese Encephalitis?
2006
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®
2004
Imported Plasmodium vivax Malaria: Demographic and Clinical Features in Nonimmune Travelers
2006
Treatment of acute vivax malaria with tafenoquine
2004
RANDOMIZED, DOUBLE-BLIND, PHASE III, PIVOTAL FIELD TRIAL OF THE COMPARATIVE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF TWO YELLOW FEVER 17D VACCINES (ARILVAX™ AND YF-VAX®) IN HEALTHY INFANTS AND CHILDREN IN PERU
2005
TAFENOQUINE FOR THE TREATMENT OF RECURRENT PLASMODIUM VIVAX MALARIA
2007
The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
1990